APRE Past Earnings image   This APRE past earnings page last updated 3/27/2023
APRE Past Earnings
PeriodPast Earnings DateGAAP
Q3 202211/9/2022-2.400
Q2 20228/12/2022-19.800
Q1 20225/16/2022-7.200
Q4 20213/15/2022-7.200
Q3 202111/8/2021-9.000
Q2 20218/12/2021-9.600
Q1 20215/6/2021-9.200
Q4 20203/16/2021-14.600
Q3 202011/5/2020-11.600
Q2 20208/11/2020-15.600
Q1 20205/15/2020-9.000
Q4 20193/26/2020-12.800
Q3 201911/14/2019-105.800
APRE Past Revenue
PeriodPast Earnings DateGAAP
Q3 202211/9/2022NA
Q2 20228/12/2022NA
Q1 20225/16/2022NA
Q4 20213/15/2022NA
Q3 202111/8/2021NA
Q2 20218/12/2021NA
Q1 20215/6/2021NA
Q4 20203/16/2021NA
Q3 202011/5/2020NA
Q2 20208/11/2020NA
Q1 20205/15/2020NA
Q4 20193/26/2020NA
Q3 201911/14/2019NA
Quotes delayed 20 minutes

Email EnvelopeFree APRE Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Aprea Therapeutics (APRE) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

APTX Past Earnings
APVO Past Earnings
APYX Past Earnings
AQST Past Earnings
ARAV Past Earnings
ARAY Past Earnings
ARCT Past Earnings
ARDS Past Earnings
ARDX Past Earnings
ARNA Past Earnings

APRE Past Earnings Q&A

What was the best and worst APRE past earnings results?
For Aprea Therapeutics, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest APRE past earnings result in our data set was -2.400/share posted in Q3 2022, while the lowest was in Q3 2019 when APRE posted -105.800/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q3 2022 when APRE reported NA in revenue, while the quarter with the lowest revenue in our data set was Q3 2022 at NA of revenue.

  Suggested answer: There are 13 APRE past earnings results in our data set.

On this page we presented the APRE past earnings date information for Aprea Therapeutics. Reviewing that APRE Past Earnings for the company, we see that the highest past earnings result in our data set was in Q3 2022, when APRE posted gaap of -2.400/share. Meanwhile the lowest APRE past earnings result was in Q3 2019, when APRE posted gaap of -105.800/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q3 2022 when APRE reported NA in revenue, while the smallest revenue quarter was Q3 2022 when APRE reported NA in revenue.

Any self directed investor doing their due diligence on APRE or any other given stock can benefit from researching all of the Aprea Therapeutics past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you PastEarnings.com to make it easy for investors to investigate Aprea Therapeutics past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for APRE. Thanks for visiting, and the next time you need to research APRE past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: Exxon Mobil YTD Return, Top Ten Hedge Funds Holding CHMA, Institutional Holders of JBI.


APRE Past Earnings | www.PastEarnings.com | Copyright © 2020 - 2023, All Rights Reserved

Nothing in PastEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.